Table 3.
SEER stage distribution according to tumor location between 2006 and 2014
| Tumor location | SEER | 2006 | 2014 | p-value |
|---|---|---|---|---|
| Overall | Localized | 11,712 (53.9) | 18,572 (66.0) | < 0.001 |
| Regional | 6,819 (31.4) | 6,335 (22.5) | ||
| Distant | 3,213 (14.8) | 3,242 (11.5) | ||
| Unknown | 4,690 | 1,705 | ||
| Cardia/Fundus | Localized | 466 (44.4) | 799 (54.2) | < 0.001 |
| Regional | 392 (37.3) | 453 (30.8) | ||
| Distant | 192 (18.3) | 221 (15.0) | ||
| Unknown | 158 | 93 | ||
| Body | Localized | 3,497 (55.6) | 6,999 (66.1) | < 0.001 |
| Regional | 1,952 (31.0) | 2,447 (23.1) | ||
| Distant | 841 (13.4) | 1,136 (10.7) | ||
| Unknown | 883 | 399 | ||
| Antrum/Pylorus | Localized | 5,308 (59.3) | 8,728 (70.8) | < 0.001 |
| Regional | 2,671 (28.8) | 2,589 (21.0) | ||
| Distant | 972 (10.9) | 1,010 (8.2) | ||
| Unknown | 1,435 | 522 |
Values are presented as number (%). SEER, Surveillance Epidemiology and End Results.